{"id":"W2161794113","doi":"10.3109/10428194.2011.652108","title":"Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy","year":2011,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Imatinib; Cumulative incidence; Internal medicine; Imatinib mesylate; Myeloid leukemia; Incidence (geometry); Oncology; Dasatinib; Tyrosine-kinase inhibitor; Nilotinib; Pediatrics; Transplantation; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005041737,0.001821299,0.00242728,0.00109048,0.0003761867,0.00009827647,0.0008200604,0.0008637375,0.0005694962],"category_scores_gemma":[0.000114551,0.001529349,0.0004845912,0.001429548,0.0008432934,0.0007193506,0.0002970372,0.000463209,0.0001403173],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.08581747,"about_ca_system_score_gemma":0.02966172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002447209,"about_ca_topic_score_gemma":0.0008416274,"domain_scores_codex":[0.9917997,0.0002615195,0.002142299,0.002133502,0.001522777,0.002140251],"domain_scores_gemma":[0.9953154,0.0003423603,0.001134521,0.001938919,0.0004163497,0.0008524602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03710879,0.00366921,0.1594709,0.002115438,0.002314142,0.002199744,0.006233958,0.0000847394,0.009326064,0.0006232269,0.0006999016,0.7761539],"study_design_scores_gemma":[0.3696922,0.01212651,0.5399015,0.003543791,0.0005675406,0.0004308356,0.0001919354,0.001945642,0.06800396,0.00008309959,0.001490395,0.00202259],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908475,0.002706527,0.0001616467,0.00003069617,0.0004873364,0.003002941,0.0001694249,0.0003130045,0.002280931],"genre_scores_gemma":[0.9936508,0.002126519,0.0009171057,0.0004790614,0.0004061679,0.0004695338,0.0008554644,0.0003733654,0.000721983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7741313,"threshold_uncertainty_score":0.9994532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0230206258151638,"score_gpt":0.2731842722756763,"score_spread":0.2501636464605125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}